(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
|
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 속성
- 밀도
- 1.52±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 1.11±0.20(Predicted)
안전
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin C화학적 특성, 용도, 생산
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 준비 용품 및 원자재
원자재
준비 용품
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 공급 업체
글로벌( 17)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
CR Corporation Lomited | |
fred.wen@crcorporation.cn | CHINA | 12069 | 58 |
Labnetwork lnc. | +86-27-50766799 +8618062016861 |
contact@labnetwork.com | China | 19994 | 58 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 7176 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 3166 | 50 |
Bide Pharmatech Ltd. | 400-1647117 15221909166 |
product02@bidepharm.com | China | 41438 | 60 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 2884 | 58 |
LaaJoo | 021-60702684 18516024827 |
huang.jiayi@sinocompound.com | China | 2654 | 58 |
Greenherbs Science and Technology Development Co., Ltd. | 010-61136123 |
pub02@greenherbs.com.cn | China | 4049 | 58 |
Shanghai Anyinuo Biomedical Technology Co., Ltd. | 021-34625901 |
420970979@qq.com | China | 5821 | 58 |
Shanghai Suifu Chemical Technology CO.,LTD. | 021-021-33738187 13341700213 |
suifuchemical@163.com | China | 585 | 58 |
(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 관련 검색:
(11bR)-4-hydroxy-2,6-bis(2,4,6-tricyclohexylphenyl)-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R-4-oxide-4-hydroxy-2,6-bis[4-(trifluoroMethyl)phenyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R- 4-oxide-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(R)-3,3'-bis(4-Methoxyphenyl)-[1,1'-Binaphthalene]-2,2'-diol
R-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
(11bR)-2,6-Di-9-anthracenyl-4-hydroxy-dinaphtho[2,1-d:1μ,2μ-f][1,3,2]dioxaphosphepin-4-oxide
R-4-oxide-4-hydroxy-2,6-bis(4-nitrophenyl)- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(R)-(-)-3,3'-BIS(TRIPHENYLSILYL)-1,1'-BINAPHTHYL-2,2'-DIYL HYDROGENPHOSPHATE, 95%
R-4-oxide-4-hydroxy-2,6-di-1-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(R)-3,3'-BIS(3,5-BIS(TRIFLUOROMETHYL)PH&
R-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
(11bR)-4-Hydroxy-2,6-bis[2,3,4,5,6-pentafluorophenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(S)-(-)-3,3'-Dibromo-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthalenediol, 97%
R-4-oxide-2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy--Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide